In vitro work demonstrates that PI3K/Akt promotes neuroblastoma cell survival, protecting cells from various apoptotic stimuli including cytotoxic chemotherapy (88, 91, 150–152). This evidence concerns the gene PIK3CB and neuroblastoma.